Business Description
EMvision Medical Devices Ltd
ISIN : AU0000028375
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 6.44 | |||||
Equity-to-Asset | 0.77 | |||||
Debt-to-Equity | 0.16 | |||||
Debt-to-EBITDA | -1.93 | |||||
Piotroski F-Score | 4/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 7.6 | |||||
3-Year EPS without NRI Growth Rate | 3.7 | |||||
3-Year Book Growth Rate | -8.8 |
Momentum Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 40.72 | |||||
9-Day RSI | 43.23 | |||||
14-Day RSI | 44.71 | |||||
6-1 Month Momentum % | -5.13 | |||||
12-1 Month Momentum % | -5.85 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 6.41 | |||||
Quick Ratio | 6.41 | |||||
Cash Ratio | 5.47 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -6.9 | |||||
Shareholder Yield % | -11.22 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -27.91 | |||||
ROA % | -17.53 | |||||
ROIC % | -323.48 | |||||
3-Year ROIIC % | -96.12 | |||||
ROC (Joel Greenblatt) % | -203.76 | |||||
ROCE % | -17.97 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 8.29 | |||||
Price-to-Tangible-Book | 8.71 | |||||
EV-to-EBIT | -73.45 | |||||
EV-to-EBITDA | -93.44 | |||||
EV-to-FCF | -22.36 | |||||
Price-to-Net-Current-Asset-Value | 9.63 | |||||
Price-to-Net-Cash | 12.2 | |||||
Earnings Yield (Greenblatt) % | -1.36 | |||||
FCF Yield % | -4.02 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
EMvision Medical Devices Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil A$) | |||
EPS (TTM) (A$) | -0.034 | ||
Beta | 2 | ||
Volatility % | 40.07 | ||
14-Day RSI | 44.71 | ||
14-Day ATR (A$) | 0.050149 | ||
20-Day SMA (A$) | 1.8595 | ||
12-1 Month Momentum % | -5.85 | ||
52-Week Range (A$) | 1.75 - 2.72 | ||
Shares Outstanding (Mil) | 85.52 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
EMvision Medical Devices Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
EMvision Medical Devices Ltd Stock Events
Event | Date | Price(A$) | ||
---|---|---|---|---|
No Event Data |
EMvision Medical Devices Ltd Frequently Asked Questions
What is EMvision Medical Devices Ltd(ASX:EMV)'s stock price today?
When is next earnings date of EMvision Medical Devices Ltd(ASX:EMV)?
Does EMvision Medical Devices Ltd(ASX:EMV) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |